Hep Email Update The New Coronavirus Appears to Affect the Liver A recent analysis found that about half of people with COVID-19, the disease caused by the coronavirus, have liver enzyme abnormalities. Advertisement FDA Approves Immunotherapy Combination for Liver Cancer A third of patients treated with Opdivo plus Yervoy experienced complete or partial tumor remission. Youths More Likely to OD if Family Members Have Opioid Prescriptions Prescriptions in the household have long been cited as a source of individuals’ misuse of opioids. #Coronavirus Get the latest updates! Hep Spring 2020 Read the latest issue! Hep Stories: Get inspired Advertisement Treatment News Youths More Likely to OD if Family Members Have Opioid Prescriptions The New Coronavirus Appears to Affect the Liver FDA Approves Immunotherapy Combination for Liver Cancer Hep C Has Plummeted Among Men Living With HIV in London Newsfeed Yes, You Should Wear a Face Mask to Cut Coronavirus Transmission Over 150 Health Experts Urge Cuomo to Release Prisoners at Risk for COVID-19 Coronavirus Antibody Tests Could Be a Game Changer Youths More Likely to OD if Family Members Have Opioid Prescriptions Treatment News Youths More Likely to OD if Family Members Have Opioid Prescriptions The New Coronavirus Appears to Affect the Liver FDA Approves Immunotherapy Combination for Liver Cancer Hep C Has Plummeted Among Men Living With HIV in London Newsfeed Yes, You Should Wear a Face Mask to Cut Coronavirus Transmission Over 150 Health Experts Urge Cuomo to Release Prisoners at Risk for COVID-19 Coronavirus Antibody Tests Could Be a Game Changer Youths More Likely to OD if Family Members Have Opioid Prescriptions

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: